Fresenius Medical Care Ssc sp. z o.o.

Business and other management consultancy activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-02-18
Share capital
4,005,000.00 PLN
Average employment (people)
407.3 (2025)
Activity description

Fresenius Medical Care Ssc is a company that provides products, therapies, and services for chronic and acute kidney dialysis and therapeutic apheresis. It focuses on healthcare solutions for patients with chronic kidney disease and cardiovascular disease. The company also engages in research related to hemodiafiltration and its impact on hospitalization for end-stage kidney disease (ESKD).

Registered address
pl. Nowy Targ 28, 50-141 Wrocław, Poland
Email
Social media
Electronic delivery address
AE:PL-40037-57270-IGSEI-35

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$557,320
Profit allocationRetained in reserve capital
Contingent liabilitiesYes
Future lease and rent payments$685,577
Management board pay$514,278
Deferred tax assets$494,015

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 88 days for 2021). All were audited by a statutory auditor.

  • 202521/07/2026
  • 202404/07/2025
  • 202307/08/2024
  • 202213/07/2023
  • 202111/10/2022
  • 202011/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

City · Wrocław287 / 13,658
Top 2.1%
Voivodeship · Dolnośląskie629 / 23,855
Top 2.6%
Country · Poland8,514 / 297,566
Top 2.9%

Results vs industry

Revenue
This companyUSD 25.85mMedianUSD 66.36kAverageUSD 1.18m
Net profit
This companyUSD 1.39mMedianUSD 1.82kAverageUSD 74.01k
Operating costs
This companyUSD 23.57mMedianUSD 50.33kAverageUSD 988.97k
Assets
This companyUSD 11.15mMedianUSD 69.52kAverageUSD 2.57m

Offer

  • Dialysis equipment
  • Dialysis therapies
  • Therapeutic apheresis

Websites

The site is available in: Polish, English, German, Spanish, Czech and 7 more. The site targets these markets: United Kingdom, United States, Spain, Czechia, Sweden and 7 more.

Public procurement

The company is the contractor in one public sector contract, worth USD 2.05k.

SubjectAmount
Authorised inspections of equipment: renal replacement therapy machine (Fresenius) Multifiltrate SN:8MUGF400; renal replacement therapy machine (Fresenius) Multifiltrate SN:9MUGG961.
$2,047

Job offers

The company has its own careers page: jobs.freseniusmedicalcare.com.

Authorized Representatives

Agnieszka Stankiewicz age 46 – Attorney-in-fact (joint)
Jakub Lorko age 39 – Attorney-in-fact (joint)
Magdalena Stach age 47 – Management Board Member
Natalia Stawarz age 45 – Management Board Member

Manner of representation

If the management board is a one-person management board, the only member of the management board represents the company independently. If the management board is a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy are authorised to represent the company.

Ownership

OwnerSharesShare valueStake
Fresenius Medical Care Beteiligungsgesellschaft Mbh
80,100$1,081,847.65100%

Beneficial owners

Person

Capital group

The company belongs to the Fresenius Medical Care AG (Germany) group, which is its direct owner. The group has 70 companies, 66 of them abroad.

NameCountry
Fresenius Medical Care PolskaPoland
Fresenius Nephrocare PolskaPoland
Biocare Technology Company LimitedHong Kong SAR China
FMC Finance II S.A R.L.Luxembourg
Fresenius Management Services, Inc.United States

Bank accounts

Registered as a VAT taxpayer on 2014-01-14.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$273

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Baxter Polska sp. z o.o.
Diagnosis S.A.
Lohmann & Rauscher Polska sp. z o.o.
Timago International Group Ossowski sp. k.
Novamed.Pl S.A.
Reha Fund sp. z o.o.
Intimex sp. z o.o. + limited partnership
MKJ Radiologia sp. z o.o.
P.A.D. Technologies Ltd sp. z o.o.
Bjeska sp. z o.o. + limited partnership

Change history

DateEvent
2019-10-28Address change
2015-10-05Share capital increase
2015-01-30Name change
2014-12-31Address change
2014-12-31Share capital increase

FAQ

Last updated: 2026-10-07